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We have developed a facile means for the refolding of miligram quantities of purified proteins that employs gel filtration chromatography. We 
demonstrate by electrophoretic mobility shift and NMR spectroscopy that human ETS-1 protein, bovine ribonucelase A and E. coli integration host 
factor can be refolded into the native conformation using this technique. We have extended this strategy to the preparation of miligram quantities 
of macromolecular complexes uitable for structural analysis by NMR spectroscopy or X-ray crystallography. The diverse challenges to overcome 
in refolding these proteins illustrates the potential of this technique as a general approach for recovery of recombinant proteins produced as insoluble 
inclusion bodies. 
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1. J.ntroduction 
Modern analysis of protein structure by NMR spec- 
troscopy or X-ray crystallography generally requires the 
overexpression and purification of tens of miligrams of 
the protein of interest. Frequently, foreign gene products 
overexpressed in the bacterium Escherichiu coli are pro- 
duced in an insoluble form known as inclusion bodies [ 13. 
The isolation of the desired gene product from inclusion 
bodies requires several washing steps, denaturation of 
the extracted protein pellet in 6-8 M guanidine hydro- 
chloride (GdmCl) and purification by reversed-phase 
high pressure liquid chromatography (HPLC) [l]. Fi- 
nally, the protein must be refolded to the native con- 
formation. 
Typical conditions for protein refolding involve 
dilution of the denatured protein to 5 10 PM into the 
appropriate folding buffer followed by dialysis and con- 
centration. The refolding problem is compounded when 
disulfide bonds need to be formed as well, often leading 
to more dilute conditions for efficient pairing of the cor- 
rect cysteine residues. We have encountered the above 
problems in the preparation of recombinant human 
ETS-1 (rETS-1) protein which is expressed as an inclu- 
sion body in E. coli and contains 9 cysteines. 
An alternative methodology of refolding using gel fil- 
tration chromatography shows promise in the prepara- 
tion of samples uitable for structural studies. Gel filtra- 
tion of the GdmCl denatured protein on a column lack- 
ing denaturant allows the refolding of up to 10 mg of 
protein, even using starting concentrations of protein 
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greater than 10 mg/ml. The protein is diluted only 5-20- 
fold during elution, depending on the column size used 
for the renaturation process. This approach has been 
successfully applied using a variety of salt, buffer and 
temperature conditions as well as for proteins of differ- 
ent sixes and compositions. Methods for refolding rETS- 
1 and bovine ribonuclease A (RNase A) are presented. 
The general applicability of this approach for the large 
scale preparation of macromolecular complexes, demon- 
strated by the the refolding of the heterodimeric protein 
E. coli integration host factor (IHF) in the presence of 
a 30 bp DNA binding site, is also pointed out. 
2. Materials and methods 
2.1. Gel filtration chromatography 
l-10 mg of the protein was solubilixed in l-2 ml of 50 mM Tris-HCl, 
50 mM dithiothreitol @‘IT), 200-500 mM NaCl and 6-8 M GdmCl, 
pH 8.5; samples were typically allowed to stand several hours or over- 
night at ambient emperature under these conditions prior to refolding. 
rETS-1 isoform proteins were refolded on a Superdex 75 HR10/30 
column (Pharmacia/LKB) equilibrated with 20 mM HEPES, 150 mM 
NaCl, 3.3 mM Na&DTA and 0.1% ‘Iken 20, pH 6.8. RNase A was 
refolded on a Sephacryl S-100 column (2.6 x 100 cm, Pharmacia) equil- 
ibrated with 20 mM sodium phosphate and 200 mM sodium chloride. 
The Superdex 75 column was run at 25°C and the Sephacryl S-100 
column was nm at 4”C, although there was little difference in the 
recovery of folded protein between these two temperatures. Flow rates 
were 0.2 ml/mm for Superdex 75 and 0.5 ml/mm for Sephacryl S-100 
under the control of a Pharmacia LCC-500 Liquid Chromatography 
Controller and a Pharmacia P-500 pump. The eluted samples were 
concentrated in a colloidian membrane apparatus using a 10,000 molec- 
ular weight cutoff nitrocellulose membrane (Schleicher & Schuell) or 
a Micro-ProDiCon apparatus (Spectrum) using a 5000 molecular 
weight cutoff membrane at 25°C. 
For the complex with IHF, uniformly i5N-1abelled and unlabelled 
protein were denatured in 8 M GdmCl and the a andb subunits isolated 
and purified using reversed phase HPLC. The proteins were reassem- 
bled as ‘5N-labelled a and natural abundance /3 by dissolving the lyo- 
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philized HPLC fractions in the above denaturation buffer (without 
D’IT) and refolding them as described above in the presence of a 30 bp 
oligonucleotide comprising the il attP I-I’ site. 
2.2. Nuclear extracts 
Nuclear extracts (NE) were prepared from 10 g of CEM cells. The 
cells were lysed in 100 ml of isotonic low salt lysis buffer (20 mM 
HEPES, pH 6.8, 0.25 M sucrose, 5 mM MgCl,, 5 mM KCl, 0.05% 
Nonidet P-40, 1% aprotinin and 0.4 mM phenylmethanesulfon- 
yltluoride (PMSF)) and centrifuged at 1000 x g for 10 min. The nuclear 
pellet was then incubated for 60 min at 4°C with 50 ml of NE buffer 
(20 mM Tris-HCl, pH 7.5, 20% glycerol, 0.35 M KCl, 0.1 mM EGTA 
and 0.5 mM EDTA). Then, the nuclear extract was centrifuged at 
100,000 x g for 60 min and dialyzed for 18 h against NE buffer contain- 
ing 100 mM KCl, 0.1% aprotinin and 0.1% NaN,. The dialyzed nuclear 
extract was then centrifuged at 100,000 x g for 30 min and stored at 
-70°C. Nuclear extracts prepared in this way contained about 5 mg/ml 
protein as determined by the BCA color reaction (Pierce). 
2.3. Electrophoretic mobility shift assay (EMSA) 
DNA sequence-specific binding by nuclear extracts from CEM cells, 
purified renatured ETSl proteins or by purified rETS1 isoforms were 
assessed by using EMSA. The nuclear extracts or puri8ed ETSl 
isoforms were incubated with “P-labelled urobe W-GATCTC- 
GAGCCGGAAGTTCGA-3’) for 60 min at rodm temperature in 4% 
glycerol, 1 mM EDTA, 5 mM DTT, 10 mM Tris-HCl, pH 7.5 and 1.0 
mg/ml bovine serum albumin (BSA). Experiments using CEM nuclear 
extracts contained 100 ngl20pl poly dIIdC as a non-speci6c competitor 
to reduce the background. After incubation, 20 ,~l were loaded onto 
4.5% or 6% nat&e polyacrylamide gels. These gels contained 
0.25 x TBE buffer (1 x TBE=89 mM Tris-HCl. 89 mM boric acid. 1 
I 
mM EDTA), 5% glycerol, 1 @/ml TEMED and 14@nl5% ammonium 
persulfate. The electrophoresis running buffer was 0.25 x TBE. The 
EMSA gels were p&m for 30 min at 250 V. 20 ,~l of sample was 
loaded and electronhoresis was continued for an additional 1.5 h. The 
EMSA gel was d&d for 30 min and exposed to X-ray film for an 
appropriate length of time. 
3. Results and discussion 
3.1. Refolding of rETS-1 
Human ETSl exists as a 51 kDa protein (full length, 
~51) and an alternatively spliced isoform of 42 kDa (p42) 
that lacks the phosphorylation domain [3]. These pro- 
teins have been isolated from CEM cells [4] as a mixture 
of p42 and p51 using an immunoaffinity technique and 
have been renatured by a lo-fold dilution into a buffer 
lacking denaturant. The recombinant p5 1 and p42 ETS 1 
proteins each contain 9 cysteines and are expressed in E. 
coli as inclusion bodies [3]. While the pattern of disulfIde 
crosslinks is unknown, the large number of potential 
crosslinks made the refolding of this protein a challenge 
[3]. Fig. 1 (lanes 3 and 5) demonstrates that the p51 and 
p42 ETSl proteins refold to the proper conformation on 
a Superdex 75 column. In EMSA assays, recombinant 
p5 1 and p42 recognize a specific binding site and exhibit 
the same mobility shift as protein found in CEM cell 
nuclear extracts (lane 8). The recovery of p42 ETSl from 
the Superdex 75 column was 71 f 15% (six determina- 
tions). Renatured ETSl isoform proteins from CEM 
Free Probe II) 
M.H. Werner et al. IFEBS Letters 345 (1994) 125-130 
12345678 
pa- 
p42 - 
Fig. 1. Mobility shift of renatured human ETSl isoforms, renatured 
recombinant human ETSl isoforms and native ETSl (CEM nuclear 
extract). The CEM nuclear extract (1 @l of 5 mg/ml protein extract) 
(lane 7), 1 ng of the renatured ETSl (lane 2) or 1 ng of renatured 
recombinant p42 (lane 4) and p51 (lane 6) isoforms were preincubated 
30 min at room temperature with 25 ng unlabelled DNA probe. Subse- 
quently, 1 ng of 32P-labelled DNA probe was added followed by an 
additional 60 min of incubation. The control CEM nuclear extract (lane 
S), control renatured ETSl (lane 1) or 1 ng of renatured recombinant 
p42 (lane 3) and p51 (lane 5) isoforms were preincubed 30 min without 
any additions before the 60 min incubation with 1 ng of 3ZP-labelled 
probe. The EMSA gels were then run as described in section 2. 
cells (Fig. 1, lane 1) show mobility shifts similar to the 
recombinant ETSl proteins (lanes 3 and 5) and to the 
ETSl isoforms found in CEM nuclear cell extracts (lane 
8). The NE protein represents the native form of ETS 
and has not been exposed to denaturants. 
3.2. Refolding of RNase A 
To contirm that the protein conformation of the re- 
folded proteins is indeed the same as that of the native 
protein, we applied this technology to RNase and qual- 
itatively analyzed the protein conformation by NMR 
spectroscopy. Comparison of NOESY spectra [5] from 
native and refolded protein demonstrates results ob- 
tained by the gel filtration technique (Fig. 2); the pattern 
and intensity of peaks in the refolded protein spectrum 
(red) is indistinguishable from that of the native protein 
spectrum (black) (note that the offset in superposition 
has been introduced for clarity). The similarity in the 
NOESY peak pattern and intensities clearly demon- 
Fig. 2. ‘H NOESY spectrum of native and refolded ribonuclease A. The 500 MHz NOESY spectrum shows a portion of the crosspeaks between 
backbone amide and side-chain protons. Native RNase is shown in black and refolded RNase is shown in red. The uniform shift in the refolded 
spectrum has been introduced for ease of inspection. 
. 
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strates that the refolded protein conformation is basi- 
cally identical to that of the native protein. Recovery of 
the refolded protein was 2 90% of the denatured protein 
loaded onto the column. 
3.3. Refolding of IHF 
Structural analysis by NMR spectroscopy of macro- 
molecular complexes requires the preparation of l-2 
mM complex samples in a final volume of 0.5 ml. In our 
experience, formation of the proper complex frequently 
requires diluting the component molecules to 10-50 PM, 
then mixing and incubating for several minutes to hours, 
followed by concentration. An easier route involves mix- 
ing the denatured protein with its cognate target and 
refolding by controlled dilution on the column. This is 
particularly useful if one of the components requires 
folding from the denatured state. IHF is a moderately 
sized basic DNA binding protein of E. coli with a mini- 
mum binding site of 30 bp [6]. IHF is comprised of two 
subunits, a andp, each of which has a molecular weight 
of approximately 11 kDa. To simplify data analysis of 
the 40 kDa complex of IHF bound to a natural DNA 
target, we prepared IHF in which only the a subunit was 
labelled with “N. In this way, is it possible to distinguish 
the signals of the two subunits by selectively filtering for 
those signals that arise from nuclei directly bonded to 
“N [7l. To this end, we prepared “N-1abelled a-subunits 
and natural abundance /?-subunits by denaturation of 
purified IHF (labelled and unlabelled) in 6 M GdmCl 
and separation of the protein subunits by reversed-phase 
HPLC. The isolated subunits were refolded in the pres- 
ence of a binding site oligonucleotide, as described in 
section 2. Fig. 3 illustrates that the oligomeric protein 
can be successfully refolded and assembled on the spe- 
cific binding site without preparing and mixing separate 
dilute solutions of all three components. The pattern of 
peaks for a-labelled protein (red) is nearly identical to 
the corresponding peaks in the uniformly labelled native 
protein (black). Recovery of the folded and assembled 
complex was 60% of the amount loaded onto the column. 
The above examples show that gel filtration permits 
the preparation of a large quantity of protein under the 
desired buffer condition(s) with a minimum of dilution 
and other sample handling steps. We have also tested the 
method with smaller columns, such as a Pharmacia Su- 
perose HR12 (20 ml column volume, data not shown) 
and have had similar success with protein refolding, al- 
beit with reduced loading capacity (e.g. only l-2 mg of 
rEts-1). Moreover, gel filtration also permits the forma- 
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tion of a large quantity of macromolecular complexes 
with little more effort than dissolving lyophilized protein 
and its cognate target into a denaturation buffer. This is 
perhaps the greatest promise of the technique, for it 
greatly reduces the number of sample handling steps for 
preparing large quantitites of macromolecular com- 
plexes suitable for structural analysis. 
One posible explanation for the relatively high success 
rate using gel filtration may be that refolding and associ- 
ation on the column occurs under essentially irreversible 
conditions, thereby circumventing a major problem in 
refolding experiments, namely kinetic competition be- 
tween folding and aggregation. The folded, native 
protien is essentially removed from the equilibrium due 
to its different flow characteristics on the column. 
While the recoveries of renatured protein are as good 
as, or often better than, more traditional gradual dialysis 
techniques, they do vary from protein to protein. Re- 
cently, we have begun to prepare complexes of the DNA- 
binding domain of rETS1 and have found that different 
constructs result in recoveries of the renatured domain 
that range from 30% to 70%. Thus, while we hnd the 
technique to be of general importance, as with many 
techniques, we expect that the method will be more suc- 
cessful with some proteins than with others. The limiting 
factor seems to be the solubility of the folding intermedi- 
ates. As the denaturant is diluted away, the partially 
renatured protein may aggregate and/or crosslink (if 
many cysteines are present), resulting in significant 
losses. While gel filtration provides an advantage in that 
these undesirable forms would be separated from the 
desired form due to the differences in molecular weight 
or flow characteristics, these other forms can also block 
the column when they form in high quantities (depending 
on the exlusion limit of the resin being used and the bead 
size of the resin). Thus, it is advisable to test the solubility 
of the protein under several conditions prior to trying a 
large scale preparation on a large column. Nonetheless, 
with these precautions in mind, we find the method to be 
widely applicable to protein refolding, and, more impor- 
tantly, to assembly of oliogmeric proteins or macromol- 
ecular complexes in large quantities. 
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Fig. 3. 15N-‘H HSQC spectrum of native and refolded integration host factor complexed with a 30 bp oligonucleotide. Native IHF complex is shown 
in black, the reconstituted complex is shown in red. Samples were prepared as described in section 2. only half of the peaks are observed in the refolded 
spectrum due to only one subunit being labelled with “N. 
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